Patent details
EP2319925 Title: Therapeutic uses of inhibitors of RTP801
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP2319925
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Lapsed by non-payment of annual fee Art. 62 ROW
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP11153604.1
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 16/08/2005
- Grant date:
- 25/07/2018
- EP Publication Date:
- 11/05/2011
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 18/10/2018
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- 01/09/2021
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 25/07/2018
- EP B1 Publication Date:
- 25/07/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 15/08/2025
- Lapsed By Expiration Date:
- Patent Validated Date:
- 30/10/2018
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 18/10/2018
- Name:
- Quark Pharmaceuticals, Inc.
- Address:
- 6501 Dumbarton Circle, FREMONT, CALIFORNIA 94555, United States of America (US)
- From:
- 18/10/2018
- Name:
- Silence Therapeutics GmbH
- Address:
- Robert-Rössle-Strasse 10, 13125 BERLIN, Germany (DE)
Historical Applicant/holder
- From:
- 25/07/2018
- To:
- 18/10/2018
- Name:
- Quark Pharmaceuticals, Inc.
- Address:
- 6501 Dumbarton Circle, FREMONT, CALIFORNIA 94555, United States of America (US)
- From:
- 25/07/2018
- To:
- 18/10/2018
- Name:
- Silence Therapeutics Aktiengesellschaft
- Address:
- Robert-Rössle-Strasse 10, 13125 BERLIN, Germany (DE)
Agent
- Name:
- dr. A. Krebs
- From:
- 29/10/2018
- Address:
- HGF B.V. Benoordenhoutseweg 46, 2596 BC, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- Feinstein, Elena
- Address:
- 76305 Rehovot, Israel (IL)
2
- Name:
- Kaufmann, Jörg
- Address:
- 13125 Berlin, Germany (DE)
3
- Name:
- Giese, Klaus
- Address:
- 13125 Berlin, Germany (DE)
Priority
1
- Priority Patent Number:
- 688943 P
- Priority Date:
- 08/06/2005
- Priority Country:
- United States of America (US)
2
- Priority Patent Number:
- 664236 P
- Priority Date:
- 22/03/2005
- Priority Country:
- United States of America (US)
3
- Priority Patent Number:
- 638659 P
- Priority Date:
- 22/12/2004
- Priority Country:
- United States of America (US)
4
- Priority Patent Number:
- 609786 P
- Priority Date:
- 14/09/2004
- Priority Country:
- United States of America (US)
5
- Priority Patent Number:
- 604668 P
- Priority Date:
- 25/08/2004
- Priority Country:
- United States of America (US)
6
- Priority Patent Number:
- 601983 P
- Priority Date:
- 17/08/2004
- Priority Country:
- United States of America (US)
7
- Priority Patent Number:
- 04019405
- Priority Date:
- 16/08/2004
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC or IDT classification:
- A61K 31/713; A61P 11/00; A61P 27/00; C12N 15/113;
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 14/22
- Publication date:
- 06/04/2022
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- CO
- Journal edition number:
- 52/18
- Publication date:
- 19/12/2018
- Description:
- Changes in the Netherlands Patent Register
3
- Bulletin Heading:
- EP3
- Journal edition number:
- 45/18
- Publication date:
- 31/10/2018
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
4
- Bulletin Heading:
- EP2
- Journal edition number:
- 31/18
- Publication date:
- 25/07/2018
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 201830
- Publication date:
- 25/07/2018
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of Legal Entity
- Deed Number:
- RC201801921A
- Date Registered:
- 18/10/2018
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. A. Krebs
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
1
- Name:
- Quark Pharmaceuticals, Inc.
- Address:
- 6501 Dumbarton Circle, FREMONT, CALIFORNIA 94555, United States of America (US)
2
- Name:
- Silence Therapeutics GmbH
- Address:
- Robert-Rössle-Strasse 10, 13125 BERLIN, Germany (DE)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 26/08/2020
- Last Annual Fee Paid Number:
- 16
- Last Annual Fee Paid Amount:
- 1000 Euro
- Payer:
- Dennemeyer and Co
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 29/10/2018 | Outgoing Correspondence | Letter no formal defects | 1 | /0/1/7/3/9/0800293710/docs/ep11153604.1_5_236482l271.pdf | ||
| 18/10/2018 | Incoming Correspondence Electronic | Accompanying letter incoming document | 1 | /0/1/7/3/9/0800293710/docs/ep11153604.1_0_incomingcorrespondenceelectronic20181018151524119.pdf | ||
| 18/10/2018 | Incoming Correspondence Electronic | EOB model | 2 | /0/1/7/3/9/0800293710/docs/ep11153604.1_1_incomingcorrespondenceelectronic20181018151525082.pdf | ||
| 18/10/2018 | Incoming Correspondence Electronic | Accompanying letter incoming document | 2 | /0/1/7/3/9/0800293710/docs/ep11153604.1_2_incomingcorrespondenceelectronic20181018151526560.pdf | ||
| 18/10/2018 | Request for Change | First filed deed | 5 | /0/1/7/3/9/0800293710/docs/ep11153604.1_3_rfc20181101104631910.pdf | ||
| 18/10/2018 | Claims | First filed claims | 3 | /0/1/7/3/9/0800293710/docs/ep11153604.1_4_claims20181018151526136.pdf |